- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/133 - Amines, e.g. amantadine having hydroxy groups, e.g. sphingosine
Patent holdings for IPC class A61K 31/133
Total number of patents in this class: 588
10-year publication summary
|
41
|
50
|
55
|
62
|
61
|
54
|
55
|
31
|
39
|
21
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Insmed Incorporated | 287 |
18 |
| NeuroDerm, Ltd. | 142 |
12 |
| The Cleveland Clinic Foundation | 1583 |
10 |
| The Regents of the University of California | 20902 |
9 |
| Dyve Biosciences, Inc. | 31 |
9 |
| OCuSOFT, Inc. | 165 |
7 |
| The Johns Hopkins University | 5938 |
5 |
| Ortho-nutra, LLC | 15 |
5 |
| Vanda Pharmaceuticals, Inc. | 391 |
5 |
| Metanoi Therapeutics, Inc. | 6 |
5 |
| Adjuvant Holdings Co.,Ltd. | 21 |
5 |
| Conopco, Inc. | 5113 |
4 |
| Janssen Pharmaceutica N.V. | 3147 |
4 |
| University of Florida Research Foundation, Inc. | 4207 |
4 |
| Hikma Pharmaceuticals LLC | 11 |
4 |
| Orasis Pharmaceuticals Ltd | 29 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3015 |
4 |
| University of Virginia Patent Foundation | 1652 |
4 |
| Beijing Baishihekang Pharmaceutical Technology (bsjpharma) Co., Ltd | 25 |
4 |
| Glaxosmithkline Intellectual Property Development Limited | 784 |
3 |
| Other owners | 463 |